Risk of chronic kidney disease in non-obese individuals with clustering of metabolic factors: A longitudinal study

Internal Medicine

Volumn 54, Issue 4, 2015, Pages 383-387

  Nishikawa, Kunihito ^a,b   Takahashi, Ken ^b   Okutani, Toshio ^a   Yamada, Ryoji ^a   Kinaga, Tsuyoshi ^a   Matsumoto, Masato ^a   Yamamoto, Masayuki ^a  

^a Shinko Hospital   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Chronic kidney disease; Metabolic syndrome; Obesity; Proteinuria; Renal dysfunction

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMORBIDITY; DYSLIPIDEMIAS; EPIDEMIOLOGY; EXERCISE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DYSFUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; OBESITY; PROTEINURIA; QUESTIONNAIRE; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTOR; SMOKING; WAIST CIRCUMFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CAUSALITY; COMORBIDITY; DYSLIPIDEMIAS; EPIDEMIOLOGY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; YOUNG ADULT;

EID: 84982306517     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.2     Document Type: Article

References (39)

1. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2 Suppl 1): S1-S266, 2002.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
3. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 80: 17-28, 2011.
4. Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 71: 159-166, 2007.
5. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int 62: 956-962, 2002.
6. Luk AO, Ma RC, So WY, et al. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease. Diabet Med 25: 1419-1425, 2008.
7. Bonnet F, Marre M, Halimi JM, et al. Waist circumference and the metabolic syndrome predict the development of elevated albumin-uria in non-diabetic subjects: the DESIR Study. J Hypertens 24: 1157-1163, 2006.
8. Lin CC, Liu CS, Li TC, Chen CC, Li CI, Lin WY. Microalbumin-uria and the metabolic syndrome and its components in the Chinese population. Eur J Clin Invest 37: 783-790, 2007.
9. Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study. Diabetes Metab Res Rev 26: 26-32, 2010.
10. Sun F, Tao Q, Zhan S. Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort. Nephrology (Carlton) 15: 84-92, 2010.
11. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140, 2005.
12. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174, 2004.
13. Kitiyakara C, Yamwong S, Cheepudomwit S, et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 71: 693-700, 2007.
14. Rashidi A, Ghanbarian A, Azizi F. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol 2: 976-983, 2007.
15. Lucove J, Vupputuri S, Heiss G, et al. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis 51: 21-28, 2008.
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.
17. The National Cholesterol Education Program (NCEP). Executive summary of the third report of the NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
18. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23: 469-480, 2006.
19. Matsuzawa Y. Metabolic syndrome--definition and diagnostic criteria in Japan. J Atheroscler Thromb 12: 301, 2005.
20. Kadota A, Hozawa A, Okamura T, et al. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000. Diabetes Care 30: 1533-1538, 2007.
21. Kokubo Y, Okamura T, Yoshimasa Y, et al. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study. Hypertens Res 31: 2027-2035, 2008.
22. Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Hypertens Res 32: 289-298, 2009.
23. The DECODE Study Group. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk? Int J Obes (Lond) 32: 757-762, 2008.
24. Lee J, Ma S, Heng D, et al. Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study. Diabetes Care 30: 343-347, 2007.
25. Tong PC, Kong AP, So WY, et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program’s Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 30: 1206-1211, 2007.
26. Kawamoto R, Ohtsuka N, Ninomiya D, Nakamura S. Carotid atherosclerosis in normal-weight metabolic syndrome. Intern Med 46: 1771-1777, 2007.
27. The Industrial Safety and Health Law and its Ordinances in Japan. [Internet]. [cited 2014 Jan 24]. Available from http://www.jniosh.g o.jp/icpro/jicosh-old/english/law/IndustrialSafetyHealth_Ordinance/ index.html
28. Wedeen RP. Occupational and environmental renal disease. Semin Nephrol 17: 46-53, 1997.
29. The Ministry of Health, Labour and Welfare, Ministry of Educa-tion, Culture, Sports, Science and Technology. Ethical Guidelines for Epidemiological Research, 2008. [Internet]. [cited 2013 July 28]. Available from: http://www.lifescience.mext.go.jp/files/pdf/37_ 139.pdf. (In Japanese).
30. Examination Committee of Criteria for “Obesity Disease” in Japan JSftSoO. New criteria for’obesity disease’ in Japan. Circ J 66: 987-992, 2002.
31. World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific Perspective: Redefining obesity and its treatment. Sydney: Health Communications, 2000. [Internet]. [cited 2013 Dec 6]. Available from: http://www.wpro.who.int/nutrition/documents/docs/Redefinin gobesity.pdf
32. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.
33. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89: 2569-2575, 2004.
34. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 7: 220, 2007.
35. Yoon YS, Lee ES, Park C, Lee S, Oh SW. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study. Int J Obes (Lond) 31: 528-534, 2007.
36. Moy FM, Bulgiba A. The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur. BMC Public Health 10: 678, 2010.
37. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364-2373, 2011.
38. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14: 1480-1486, 2003.
39. Oda E. Multiple metabolic risk factors per se are more important than anthropometric cutoff points to predict morbid effects of obesity. Intern Med 49: 2653, 2010.